Detailed Analysis of the Scope and Claims of United States Patent 11,400,077
Introduction
United States Patent 11,400,077 is a significant patent in the pharmaceutical sector, particularly protecting the drug RYZUMVI. To understand the full implications and landscape of this patent, it is crucial to delve into its scope, claims, and the broader patent landscape.
Patent Overview
Patent Number and Title
The patent in question is U.S. Patent 11,400,077. While the specific title of the patent is not provided in the sources, it is known to protect the pharmaceutical drug RYZUMVI[5].
Drug Protected: RYZUMVI
RYZUMVI is a pharmaceutical drug, and this patent ensures its exclusivity in the market. Understanding the drug's application and its therapeutic area is essential for grasping the patent's significance.
Scope of the Patent
Claims
The scope of a patent is primarily defined by its claims. These claims outline what is protected by the patent and what would constitute infringement. For U.S. Patent 11,400,077, the claims would typically include specific formulations, methods of use, or other unique aspects of RYZUMVI that distinguish it from other drugs.
Claim Types
Patents can include various types of claims, such as:
- Composition of Matter Claims: These claims protect the chemical composition of the drug.
- Method of Use Claims: These claims protect specific ways in which the drug can be used.
- Method of Manufacture Claims: These claims protect the processes used to manufacture the drug[3].
Patent Claims Research Dataset
For a detailed analysis, one could refer to the Patent Claims Research Dataset provided by the USPTO. This dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. While this dataset may not include the specific patent in question, it provides a framework for understanding how claims are structured and analyzed[3].
Patent Landscape
Prior Art and Citation Data
Understanding the prior art and citation data is crucial for assessing the novelty and non-obviousness of the patent. Tools like the Common Citation Document (CCD) application can provide a single point of access to up-to-date citation data relating to the patent applications of the IP5 Offices, helping to visualize the prior art cited by several offices on a single page[1].
Global Dossier
The Global Dossier service allows users to see the patent family for a specific application, including all related applications filed at participating IP Offices. This can help in understanding the global reach and related filings of the patent[1].
Competitor Patents
Analyzing competitor patents in the same therapeutic area can provide insights into the competitive landscape. This involves searching through databases like the Patent Public Search tool or visiting the USPTO Public Search Facility to access patent and trademark information[1].
Search and Analysis Tools
Patent Public Search
The Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It offers enhanced access to prior art through two modern interfaces, improving the overall patent searching process[1].
Patent and Trademark Resource Centers (PTRCs)
Local PTRCs can provide additional resources and training in patent search techniques, which can be invaluable for a detailed analysis of the patent landscape[1].
Privacy and Security Considerations
Privacy Threshold Analysis (PTA)
For systems like the Patent Search System – Specialized Search (PSS-SS), a Privacy Threshold Analysis is conducted to determine if a Privacy Impact Assessment (PIA) is necessary. This ensures that the system, which provides access to highly specialized data, maintains the privacy and security of the information it handles[4].
Key Takeaways
- Patent Scope: The scope of U.S. Patent 11,400,077 is defined by its claims, which protect the drug RYZUMVI.
- Claims Analysis: Understanding the types of claims (composition of matter, method of use, etc.) is crucial for determining the patent's protection.
- Patent Landscape: Tools like the Global Dossier and Common Citation Document help in understanding the global and prior art context.
- Search Tools: Utilizing the Patent Public Search tool and PTRCs can enhance the analysis of the patent landscape.
- Privacy and Security: Ensuring the privacy and security of the data handled by patent search systems is vital.
FAQs
Q: What is the primary drug protected by U.S. Patent 11,400,077?
A: The primary drug protected by U.S. Patent 11,400,077 is RYZUMVI.
Q: How can one analyze the claims of a patent like U.S. Patent 11,400,077?
A: One can analyze the claims by referring to the patent document itself and using resources like the Patent Claims Research Dataset provided by the USPTO.
Q: What is the Global Dossier service, and how does it help in patent analysis?
A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and related citation data.
Q: What tools are available for searching prior art related to U.S. patents?
A: Tools like the Patent Public Search, Global Dossier, and Common Citation Document are available for searching prior art and understanding the patent landscape.
Q: Why is a Privacy Threshold Analysis important for patent search systems?
A: A Privacy Threshold Analysis is important to determine if a Privacy Impact Assessment is necessary, ensuring the privacy and security of the information handled by the system.
Sources
- USPTO - Search for patents: https://www.uspto.gov/patents/search
- ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
- USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
- U.S. Department of Commerce - Privacy Threshold Analysis for the Patent Search System: https://www.commerce.gov/sites/default/files/2023-09/uspto_pss-ss_pta_2021.pdf
- DrugPatentWatch - Patent 11,400,077: https://www.drugpatentwatch.com/p/patent/11400077
